Sapitinib is an erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. erbB kinase inhibitor AZD8931 binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB. The erbB protein family, also called the epidermal growth factor receptor (EGFR) family, plays major roles in tumor cell proliferation and tumor vascularization. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include sapitinibum. Its PubChem CID is 11488320.
Sapitinib
| CAS No | 848942-61-0 |
|---|---|
| Molecular Formula | C23H25ClFN5O3 |
| Molecular Weight | 473.9 g/mol |
| Synonyms | 2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sapitinib is an erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. erbB kinase inhibitor AZD8931 binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB.
The listed CAS number is 848942-61-0.
The listed molecular formula is C23H25ClFN5O3.
The listed molecular weight is 473.9 g/mol.
2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide.
The source lists sapitinibum.